McKesson Corporation logo
McKesson Corporation (MCK)
Compare

McKesson Corporation (MCK) PE Ratio: 19.51

popular:market cap|pe ratio|revenue|price history|total return

Is McKesson Corporation’s P/E ratio high or low?

McKesson Corporation's P/E ratio of 19.51 is 26% below its 4-year average of 26.39, near the low end of its 4-year range (14.72–47.53).

As of Friday, June 19, 2026. 27.27% below its 12-month average of 26.82.

PE Ratio (19.51) = Close Price ($750.63) / Diluted TTM EPS ($38.47)

PEG Ratio|P/B Ratio|EPS|All Metrics

MCK PE Ratio Chart

MCK PE Ratio
19.51-30.91% 1Y
Zoom

MCK Average PE Ratio Chart

MCK Current vs Average PE Ratio Chart

MCK PE Ratio Metrics

PE RATIO

19.51

PE RATIO AVG TTM

26.82

PE RATIO AVG 3Y

24.60

PE RATIO AVG 5Y

26.08

PE RATIO AVG 10Y

23.01

PE RATIO AVG 15Y

23.44

PE RATIO AVG 20Y

20.96

CURRENT VS TTM AVG

-27.27%

CURRENT VS 3Y AVG

-20.69%

CURRENT VS 5Y AVG

-25.18%

CURRENT VS 10Y AVG

-15.20%

CURRENT VS 15Y AVG

-16.78%

CURRENT VS 20Y AVG

-6.91%

MCK Competitors' PE Ratio

NAMEMARKET CAPPE RATIOTTM3Y5Y
McKesson Corporation (MCK)$87.88B19.5126.8224.6026.08
Elevance Health Inc. (ELV)vs ›$84.37B16.5213.8916.3717.74
HCA Healthcare, Inc. (HCA)vs ›$83.23B12.9017.1315.8614.67
Medtronic plc (MDT)vs ›$101.86B21.2725.1826.9628.58
Cigna Corporation (CI)vs ›$73.88B11.8413.7519.1516.75
Boston Scientific Corporation (BSX)vs ›$67.35B18.8948.7665.5984.84
Bristol-Myers Squibb Company (BMY)vs ›$110.27B15.1717.5616.3119.34
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$62.84B14.8616.3320.8217.83
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$114.63B26.7929.4729.2727.28
Stryker Corporation (SYK)vs ›$119.03B34.8545.8943.5644.59

P/E vs. its own history

At 19.5, P/E is in its normal range, sitting higher than 51% of its 20-year history.

20-year low

6.2

median

19.4

20-year high

2410.0

cheaperricher

P/E Comparison

Trailing P/E

19.5

Forward P/E

14.9

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$750.63

÷

Forward EPS (Est.)

$50.39

=

Forward P/E

14.90

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

McKesson Corporation PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

McKesson Corporation PE Ratio FAQ

What is the P/E ratio for McKesson Corporation (MCK)?
The P/E ratio for MCK stock is 19.51.
Is McKesson Corporation's P/E ratio high or low?
McKesson Corporation's P/E ratio of 19.51 is 26% below its 4-year average of 26.39, near the low end of its 4-year range (14.72–47.53).
What is the TTM average P/E ratio for McKesson Corporation (MCK)?
The TTM average P/E ratio for MCK stock is 26.82.
What is the 3Y average P/E ratio for McKesson Corporation (MCK)?
The 3Y average P/E ratio for MCK stock is 24.60.
What is the 5Y average P/E ratio for McKesson Corporation (MCK)?
The 5Y average P/E ratio for MCK stock is 26.08.
What is the 10Y average P/E ratio for McKesson Corporation (MCK)?
The 10Y average P/E ratio for MCK stock is 23.01.
What is the 15Y average P/E ratio for McKesson Corporation (MCK)?
The 15Y average P/E ratio for MCK stock is 23.44.
What is the 20Y average P/E ratio for McKesson Corporation (MCK)?
The 20Y average P/E ratio for MCK stock is 20.96.

McKesson Corporation PE Ratio History

DATEPE RATIO
2026-06-1819.51
2026-06-1720.27
2026-06-1620.42
2026-06-1520.27
2026-06-1220.38
2026-06-1120.46
2026-06-1020.55
2026-06-0920.39
2026-06-0819.93
2026-06-0520.16
2026-06-0419.68
2026-06-0319.22
2026-06-0219.15
2026-06-0119.10
2026-05-2919.30
2026-05-2819.68
2026-05-2719.66
2026-05-2619.61
2026-05-2219.91
2026-05-2119.92
2026-05-2019.62
2026-05-1919.80
2026-05-1820.17
2026-05-1519.77
2026-05-1419.42
2026-05-1319.16
2026-05-1219.10
2026-05-1118.85
2026-05-0819.13
2026-05-0719.62
2026-05-0621.39
2026-05-0523.04
2026-05-0423.23
2026-05-0123.41
2026-04-3023.45
2026-04-2923.66
2026-04-2824.01
2026-04-2723.82
2026-04-2423.82
2026-04-2324.05
2026-04-2223.85
2026-04-2124.22
2026-04-2024.71
2026-04-1724.92
2026-04-1624.95
2026-04-1524.83
2026-04-1424.81
2026-04-1324.87
2026-04-1024.90
2026-04-0925.12
2026-04-0825.06
2026-04-0724.64
2026-04-0624.64
2026-04-0225.43
2026-04-0125.09
2026-03-3124.89
2026-03-3024.74
2026-03-2724.74
2026-03-2624.84
2026-03-2525.30
2026-03-2425.36
2026-03-2325.22
2026-03-2025.48
2026-03-1925.85
2026-03-1826.47
2026-03-1727.09
2026-03-1627.13
2026-03-1327.06
2026-03-1227.16
2026-03-1126.87
2026-03-1026.71
2026-03-0927.10
2026-03-0626.44
2026-03-0526.79
2026-03-0428.15
2026-03-0328.64
2026-03-0228.50
2026-02-2728.40
2026-02-2628.03
2026-02-2527.70
2026-02-2427.53
2026-02-2327.30
2026-02-2027.25
2026-02-1926.95
2026-02-1827.24
2026-02-1727.22
2026-02-1326.88
2026-02-1226.34
2026-02-1127.41
2026-02-1026.90
2026-02-0927.68
2026-02-0627.28
2026-02-0527.55
2026-02-0423.64
2026-02-0326.50
2026-02-0226.35
2026-01-3025.88
2026-01-2925.60
2026-01-2825.74
2026-01-2725.97
2026-01-2625.74
2026-01-2325.54
2026-01-2225.44
2026-01-2125.63
2026-01-2025.59
2026-01-1626.17
2026-01-1526.28
2026-01-1425.97
2026-01-1325.65
2026-01-1225.70
2026-01-0925.41
2026-01-0825.36
2026-01-0725.65
2026-01-0625.73
2026-01-0525.68
2026-01-0225.64
2025-12-3125.54
2025-12-3025.76
2025-12-2925.85
2025-12-2625.79
2025-12-2425.73
2025-12-2325.71
2025-12-2225.48
2025-12-1925.54
2025-12-1825.24
2025-12-1725.11
2025-12-1625.22
2025-12-1525.62
2025-12-1225.34
2025-12-1125.39
2025-12-1025.31
2025-12-0924.75
2025-12-0824.84
2025-12-0525.17
2025-12-0425.35
2025-12-0325.07
2025-12-0225.83
2025-12-0126.68
2025-11-2827.43
2025-11-2627.51
2025-11-2527.69
2025-11-2427.09
2025-11-2126.96
2025-11-2026.45
2025-11-1926.54
2025-11-1826.80
2025-11-1726.63
2025-11-1426.22
2025-11-1326.35
2025-11-1226.18
2025-11-1126.66
2025-11-1026.75
2025-11-0726.53
2025-11-0626.73
2025-11-0526.28
2025-11-0433.59
2025-11-0332.73
2025-10-3132.38
2025-10-3032.94
2025-10-2932.23
2025-10-2832.11
2025-10-2732.38
2025-10-2431.99
2025-10-2331.64
2025-10-2231.75
2025-10-2131.42
2025-10-2031.44
2025-10-1731.36
2025-10-1630.94
2025-10-1531.60
2025-10-1431.20
2025-10-1330.71
2025-10-1030.47
2025-10-0930.25
2025-10-0830.16
2025-10-0729.93
2025-10-0629.58
2025-10-0329.45
2025-10-0230.28
2025-10-0130.53
2025-09-3030.83
2025-09-2930.40
2025-09-2630.35
2025-09-2529.39
2025-09-2430.35
2025-09-2329.58
2025-09-2227.81
2025-09-1927.87
2025-09-1827.54
2025-09-1727.62
2025-09-1627.67
2025-09-1528.05
2025-09-1228.39
2025-09-1128.72
2025-09-1028.18
2025-09-0928.15
2025-09-0827.81
2025-09-0527.43
2025-09-0427.59
2025-09-0327.57
2025-09-0227.60
2025-08-2927.40
2025-08-2827.18
2025-08-2727.27
2025-08-2627.16
2025-08-2527.09
2025-08-2227.51
2025-08-2128.17
2025-08-2028.05
2025-08-1927.01
2025-08-1826.78
2025-08-1526.86
2025-08-1426.89
2025-08-1326.46
2025-08-1226.30
2025-08-1126.85
2025-08-0826.68
2025-08-0726.47
2025-08-0628.08
2025-08-0527.49
2025-08-0427.55
2025-08-0127.07
2025-07-3126.87
2025-07-3027.70
2025-07-2927.59
2025-07-2827.36
2025-07-2527.58
2025-07-2427.52
2025-07-2327.66
2025-07-2227.49
2025-07-2127.56
2025-07-1827.50
2025-07-1727.52
2025-07-1627.73
2025-07-1527.54
2025-07-1427.72
2025-07-1127.49
2025-07-1027.68
2025-07-0928.18
2025-07-0828.06
2025-07-0728.49
2025-07-0327.87
2025-07-0227.33
2025-07-0128.20
2025-06-3028.39
2025-06-2728.12
2025-06-2627.97
2025-06-2527.83
2025-06-2427.93
2025-06-2327.97
2025-06-2027.93
2025-06-1828.24
2025-06-1728.07
2025-06-1627.88
2025-06-1328.21
2025-06-1228.31
2025-06-1127.81
2025-06-1027.31
2025-06-0927.44
2025-06-0627.62

Showing the most recent 260 of 4,502 data points. The chart above shows the full history.

Related Metrics

PEG RatioP/B RatioEPSAll Metrics
See the Lowest P/E Ratio Stocks ranking →

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX
44,000 employees
www.mckesson.com
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Brian S. Tyler
View full financials